JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Pascolizumab is an investigational humanized monoclonal antibody that binds to and neutralizes the activity of IL-4, was shown to inhibit upstream and downstream events associated with asthma, including TH2 cell activation and IgE synthesis in monkeys.